New immunosuppressants in BMT/GVHD

Transplant Proc. 2001 May;33(3):2220-2. doi: 10.1016/s0041-1345(01)01946-7.
No abstract available

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Bone Marrow Transplantation / immunology*
  • Cytomegalovirus / physiology
  • Cytomegalovirus Infections / physiopathology
  • Daclizumab
  • Drug Therapy, Combination
  • Graft vs Host Disease / drug therapy*
  • Graft vs Host Disease / prevention & control*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunoglobulin G / adverse effects
  • Immunoglobulin G / therapeutic use*
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / therapeutic use*
  • Virus Activation

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Daclizumab
  • Mycophenolic Acid